Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
| ▸ | CTSB | P07858 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 6/20 | 0.33 |
| ▸ | MAOA | P21397 | 4/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | RCOR1 | Q9UKL0 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.33 |
| ▸ | PSMD11 | O00231 | 2/20 | 0.33 |
| ▸ | PSMD12 | O00232 | 2/20 | 0.33 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.33 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.33 |
| ▸ | PSMD3 | O43242 | 2/20 | 0.33 |
| ▸ | PSMC3 | P17980 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23366239 | 0.97 | CTSS (0.35) | ALDH1A1CYP1A2CTSLCTSBCTSS | |
| SCHEMBL24180261 | 0.84 | PSMB5 (0.34) | ALDH1A1GAACYP1A2S1PR1KDM1A | |
| SCHEMBL24180291 | 0.82 | FPR2 (0.31) | — | |
| SCHEMBL23366189 | 0.81 | PSMB5 (0.36) | ALDH1A1S1PR1CYP3A4TSHRPSMB5 | |
| SCHEMBL23366221 | 0.81 | PSMB5 (0.36) | ALDH1A1S1PR1CYP3A4TSHRPSMB5 | |
| SCHEMBL23366166 | 0.75 | CASP1 (0.47) | GAA | |
| SCHEMBL23366183 | 0.74 | SMN1; SMN2 (0.52) | ALDH1A1GAACYP1A2KDM1AMAOA | |
| SCHEMBL23366182 | 0.72 | PSMB5 (0.34) | ALDH1A1CYP1A2CTSLCTSBCTSS | |
| SCHEMBL23366220 | 0.69 | — | — | |
| SCHEMBL23366205 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11007274-B2 | Compounds for medicinal applications | AusVir Therapeutics Pty Ltd (AU) | 2021-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11007274-B2 | Compounds for medicinal applications | HAVCR2, ENGASE, DNPEP | ALDH1A1 735/4885GAA 229/4885CYP1A2 1314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.